Stay updated on PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.
Latest updates to the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe Locations section was expanded with many new sites across the US and other countries, and older location blocks were removed; the revision tag was updated to v3.3.3.SummaryDifference2%
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedPubMed publications note updated to indicate that publications are automatically filled from PubMed. The page revision tag updated to v3.3.2.SummaryDifference0.0%
- Check38 days agoChange DetectedRemoved a boilerplate notice about government funding and NIH operating status. The rest of the page content remains focused on the study details.SummaryDifference0.1%
- Check46 days agoChange DetectedHamburg locations were added and formatted as Hamburg, Hamburg, Germany, replacing the previous 'City state of Hamburg' designation. The PYNNACLE study protocol reference was updated to a newer Future Oncol article.SummaryDifference0.1%
- Check53 days agoChange DetectedLocation count updated to 75 locations (replacing 82), enrollment target listed as 300, and timelines updated to primary completion 2026-08-15 and study completion 2027-12-31. New investigators added and eligibility/exclusion criteria as well as Phase 1/2 dosing and combination therapy details updated.SummaryDifference1%
- Check61 days agoChange DetectedNo significant changes detected between the two screenshots; the page content and layout remain consistent with the ClinicalTrials.gov study record.SummaryDifference0.2%
Stay in the know with updates to PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.